This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: The Cleveland Clinic Foundation. Active years: 2015-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2017
Title: Raed Dweik: Innovator in Medical Diagnostics
Introduction
Raed Dweik is a prominent inventor based in Moreland Hills, OH (US). He has made significant contributions to the field of medical diagnostics, particularly in the area of alcoholic hepatitis. With a total of 2 patents, Dweik's work is paving the way for improved diagnostic methods.
Latest Patents
Dweik's latest patents focus on innovative methods for diagnosing acute alcoholic hepatitis. One of the methods involves determining the levels of trimethylamine in a biological sample obtained from a subject. The level of trimethylamine is compared to a control value, and if it exceeds this value, the subject is diagnosed with alcoholic hepatitis. Another aspect of his invention includes assessing a subject's condition by determining both the levels of trimethylamine and pentane in a biological sample. A TAP score is calculated based on these concentrations, and a diagnosis of alcoholic hepatitis is made if the TAP score exceeds a control value.
Career Highlights
Raed Dweik is affiliated with the Cleveland Clinic Foundation, where he continues to advance his research and innovations in medical diagnostics. His work is recognized for its potential to enhance the accuracy and efficiency of diagnosing alcoholic hepatitis.
Collaborations
Dweik collaborates with esteemed colleagues such as Ibrahim Hanouneh and David Grove, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Raed Dweik's contributions to medical diagnostics, particularly in diagnosing alcoholic hepatitis, highlight his role as an influential inventor. His innovative methods are set to improve patient outcomes and advance the field of medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
